Orum Therapeutics Inc. (475830)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
16,020. 00
-1,690
-9.5426%
₩
1.33T Market Cap
- P/E Ratio
- Div Yield
213,731 Volume
- Eps
₩ 17,710
Previous Close Want to track 475830 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Orum Therapeutics Inc. (475830) Statistics
Valuation metrics
Market Cap 1.33T
Enterprise value 391.72B
Trailing P/E (ttm) 22.34
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 10,089.17
Price/Book (mrq) 2.24
Enterprise Value/Revenue 9,659.47
Enterprise Value/EBITDA 18.22
Overview
Shares outstanding 21.16M
Float 15.27M
Shares short -
% Held by insiders 0.16%
% Held by institutions 0.02%
Average volume (10 days) 382.73K
Average volume (90 days) 265.73K
Price summary
52-Week low 15,710
52-Week high 146,600
Beta -
50-Day moving average 45,445.94
200-Day moving average 63,102.76
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 456.46%
Operating margin -1,618.18%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.24%
Income Statement
Revenue (ttm) 23.56M
Revenue per share (ttm) 1.88
Quarterly revenue growth (yoy) -0.78%
Gross profit (ttm) 23.31M
EBITDA -48.46B
Net income to common (ttm) -41.97B
Diluted EPS (ttm) 858.03
Quarterly earnings growth (yoy) -0.77%
Balance Sheet
Total cash (mrq) 132.6B
Total cash per share (mrq) 11,676.11
Total debt (mrq) 25.5B
Total Debt/Equity (mrq) 0.52
Current ratio (mrq) 3.12%
Book value per share (mrq) 8,621.68
Cash Flow
Cash flow statement -35.99B
Levered free cash flow (LFCF) -19.89B
2026 © Marketlog. All Rights Reserved.
